References
- Bolhuls G, Kussendrager K, Langridge J. 2004. New developments in spray-dried lactose. Pharm Technol. 22:26–31.
- Cao Q-R, Choi H-G, Kim D-C, Lee B-J. 2004. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int J Pharm. 274:107–117.
- Chen C-M, Alli D, Igga MR, Czeisler JL. 1990. Comparison of moisture-activated dry granulation profess with conventional granulation methods for sematilide hydrochloride tablets. Drug Dev Ind Pharm. 16:379–394.
- Denny P. 2002. Compaction equations: a comparison of the Heckel and Kawakita equations. Powder Technol. 127:162–172.
- Dugar RP, Gajera BY, Dave RH. 2016. Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407. AAPS PharmSciTech. 17:1428–1440.
- Escudero J, Ferrero C, Jiménez-Castellanos M. 2008. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades. Int J Pharm. 351:61–73.
- Escudero J, Ferrero C, Jiménez-Castellanos M. 2010. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution. Int J Pharm. 387:56–64.
- Fell J, Newton J. 1971. Effect of particle size and speed of compaction on density changes in tablets of crystalline and spray-dried lactose. J Pharm Sci. 60:1866–1869.
- Freitag F, Runge J, Kleinebudde P. 2005. Coprocessing of powdered cellulose and magnesium carbonate: direct tableting versus tableting after roll compaction/dry granulation. Pharm Dev Technol. 10:353–362.
- Gajera BY, Dugar RP, Dave RH. 2016. Formulation development and optimization of ibuprofen poloxamer melt granules using hydrophilic excipients. Br J Pharm Res. 13(6):1–19.
- Gupta P. 2006. Improved excipient functionality by coprocessing. In: Katdare A, Chaubal M, editors. Excipient development for pharmaceutical, biotechnology, and drug delivery systems. 1st ed. New York (NY): Taylor and Francis Group LLC; p. 109–124.
- Heckel R. 1961a. An analysis of powder compaction phenomena. Trans Metall Soc AIME. 221:1001–1008.
- Heckel R. 1961b. Density-pressure relationships in powder compaction. Trans Metall Soc AIME. 221:671–675.
- Herting MG, Kleinebudde P. 2007. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties. Int J Pharm. 338:110–118.
- Kawakita K, Hattori I, Kishigami M. 1974. Characteristic constants in Kawakita's powder compression equation. J Res Assoc Powder Technol. 11:453–460.
- Khomane KS, Bansal AK. 2013. Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs. AAPS PharmSciTech. 14:1169–1177.
- Khomane KS, More PK, Bansal AK. 2012. Counterintuitive compaction behavior of clopidogrel bisulfate polymorphs. J Pharm Sci. 101:2408–2416.
- Kuentz M, Leuenberger H. 1999. Pressure susceptibility of polymer tablets as a critical property: a modified Heckel equation. J Pharm Sci. 88:174–179.
- Lay Peng Soh J, Valeria Liew C, Wan Sia Heng P. 2015. Impact of excipient variability on drug product processing and performance. CPD. 21:5890–5899.
- Moreton C. 2010. Trends in pharmaceutical excipients: an update. Am Pharm Rev. 13:22–27.
- Nachaegari SK, Bansal AK. 2004. Coprocessed excipients for solid dosage forms. Pharm Technol. 28:52–65.
- Nicklasson F, Alderborn G. 2000. Analysis of the compression mechanics of pharmaceutical agglomerates of different porosity and composition using the Adams and Kawakita equations. Pharm Res. 17:949–954.
- Nordström J, Klevan I, Alderborn G. 2009. A particle rearrangement index based on the Kawakita powder compression equation. J Pharm Sci. 98:1053–1063.
- Passerini N, Calogerà G, Albertini B, Rodriguez L. 2010. Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes. Int J Pharm. 391:177–186.
- Portillo PM, Ierapetritou M, Tomassone S, McDade C, Clancy D, Avontuur PP, Muzzio FJ. 2008. Quality by design methodology for development and scale-up of batch mixing processes. J Pharm Innov. 3:258–270.
- Saha A, Grabowski H, Birnbaum H, Greenberg P, Bizan O. 2006. Generic competition in the US pharmaceutical industry. Int J Econ Business. 13:15–38.
- Salbu L, Bauer-Brandl A, Alderborn G, Tho I. 2012. Effect of degree of methoxylation and particle size on compression properties and compactibility of pectin powders. Pharm Dev Technol. 17:333–343.
- Sarode A, Wang P, Cote C, Worthen DR. 2013. Low-viscosity hydroxypropylcellulose (HPC) grades SL and SSL: versatile pharmaceutical polymers for dissolution enhancement, controlled release, and pharmaceutical processing. AAPS PharmSciTech. 14:151–159.
- Stulzer H, Rodrigues P, Cardoso T, Matos J, Silva M. 2008. Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations. J Therm Anal Calorim. 91:323–328.
- Sun CC. 2011. Decoding powder tabletability: roles of particle adhesion and plasticity. J Adhes Sci Technol. 25:483–499.
- Zecevic DE, Meier R, Daniels R, Wagner K-G. 2014. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL-mixtures. Eur J Pharm Biopharm. 87:264–270.
- Zhang GG, Law D, Schmitt EA, Qiu Y. 2004. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev. 56:371–390.
- Zhang Y, Law Y, Chakrabarti S. 2003. Physical properties and compact analysis of commonly used direct compression binders. AAPS PharmSciTech. 4:489–499.